232 related articles for article (PubMed ID: 28064104)
1. Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles.
Ita K
Biomed Pharmacother; 2017 Mar; 87():311-320. PubMed ID: 28064104
[TBL] [Abstract][Full Text] [Related]
2. Topical and transdermal delivery of antisense oligonucleotides.
Brand RM
Curr Opin Mol Ther; 2001 Jun; 3(3):244-8. PubMed ID: 11497348
[TBL] [Abstract][Full Text] [Related]
3. Transdermal iontophoretic drug delivery: advances and challenges.
Ita K
J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
[TBL] [Abstract][Full Text] [Related]
4. Intradermal delivery of antisense oligonucleotides by the pulse depolarization iontophoretic system.
Aramaki Y; Arima H; Takahashi M; Miyazaki E; Sakamoto T; Tsuchiya S
Biol Pharm Bull; 2003 Oct; 26(10):1461-6. PubMed ID: 14519955
[TBL] [Abstract][Full Text] [Related]
5. Oral delivery of siRNA and antisense oligonucleotides.
Akhtar S
J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid delivery for therapeutic applications.
Gupta A; Andresen JL; Manan RS; Langer R
Adv Drug Deliv Rev; 2021 Nov; 178():113834. PubMed ID: 34492233
[TBL] [Abstract][Full Text] [Related]
7. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.
Fattal E; Bochot A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1203-23. PubMed ID: 17097190
[TBL] [Abstract][Full Text] [Related]
8. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.
Fattal E; Bochot A
Int J Pharm; 2008 Dec; 364(2):237-48. PubMed ID: 18619528
[TBL] [Abstract][Full Text] [Related]
9. Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System.
Mendonça MCP; Kont A; Aburto MR; Cryan JF; O'Driscoll CM
Mol Pharm; 2021 Apr; 18(4):1491-1506. PubMed ID: 33734715
[TBL] [Abstract][Full Text] [Related]
10. Irontophoresis: transdermal delivery of iron by iontophoresis.
Murthy SN; Vaka SR
J Pharm Sci; 2009 Aug; 98(8):2670-6. PubMed ID: 19117049
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat.
Kigasawa K; Kajimoto K; Hama S; Saito A; Kanamura K; Kogure K
Int J Pharm; 2010 Jan; 383(1-2):157-60. PubMed ID: 19732811
[TBL] [Abstract][Full Text] [Related]
12. [Augmentation of transdermal drug penetration].
Préat MV
Bull Mem Acad R Med Belg; 1998; 153(5-6):295-300; discussion 301-2. PubMed ID: 9988935
[TBL] [Abstract][Full Text] [Related]
13. Innovative nanotechnologies for the delivery of oligonucleotides and siRNA.
Toub N; Malvy C; Fattal E; Couvreur P
Biomed Pharmacother; 2006 Nov; 60(9):607-20. PubMed ID: 16952435
[TBL] [Abstract][Full Text] [Related]
14. Advances in transdermal siRNAs delivery: A review of current research progress.
Sufianov A; Beilerli A; Kudriashov V; Ilyasova T; Wenjie B; Beylerli O
Noncoding RNA Res; 2023 Sep; 8(3):392-400. PubMed ID: 37275244
[TBL] [Abstract][Full Text] [Related]
15. Transdermal delivery of antisense oligonucleotides.
Brand RM; Iversen PL
Methods Mol Med; 2005; 106():255-69. PubMed ID: 15375321
[No Abstract] [Full Text] [Related]
16. Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides.
Senn C; Hangartner C; Moes S; Guerini D; Hofbauer KG
Eur J Pharmacol; 2005 Oct; 522(1-3):30-7. PubMed ID: 16213482
[TBL] [Abstract][Full Text] [Related]
17. Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA.
de Martimprey H; Vauthier C; Malvy C; Couvreur P
Eur J Pharm Biopharm; 2009 Mar; 71(3):490-504. PubMed ID: 18977435
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive approach for enhancing small interfering RNA delivery percutaneously.
Aljuffali IA; Lin YK; Fang JY
Expert Opin Drug Deliv; 2016; 13(2):265-80. PubMed ID: 26592090
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.
Juliano R; Alam MR; Dixit V; Kang H
Nucleic Acids Res; 2008 Jul; 36(12):4158-71. PubMed ID: 18558618
[TBL] [Abstract][Full Text] [Related]
20. Antisense drug discovery and development technology considered in a pharmacological context.
Crooke ST; Liang XH; Crooke RM; Baker BF; Geary RS
Biochem Pharmacol; 2021 Jul; 189():114196. PubMed ID: 32800852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
